Research Site

São Jose Do Rio Preto 15090-000

1 studies enrolling now · 2 studies all time

What they study most

Gastric Cancer, Papillary Renal Cell Carcinoma

Studies at this site

• Ph1b/2 Study of the Safety and Efficacy of T-DXd Combinations in Advanced HER2-expressing Gastric Cancer (DESTINY-Gastric03) — Recruiting now
• Savolitinib Plus Durvalumab Versus Sunitinib and Durvalumab Monotherapy in MET-Driven, Unresectable and Locally Advanced or Metastatic PRCC — Running, not enrolling